Who is sponsoring NCT04793984?

NCT04793984 is sponsored by Marinomed Biotech AG.

What drugs are being tested in NCT04793984?

Interventions: Carragelose, NaCl.

What is the status of NCT04793984?

NCT04793984 is currently COMPLETED.

Last reviewed 2022-08-29 · How we verify

Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

NCT04793984 NA COMPLETED

The current study will investigate the tolerability and efficacy of inhaled Carragelose® versus saline in hospitalized COVID-19 patients. As SARS-CoV-2 replicates readily in the lung, it is planed to apply Carragelose® in an inhalative form. Hospitalized COVID-19 patients with respiratory symptoms will inhale Inhaleen for 5 days.

Details

Lead sponsor	Marinomed Biotech AG
Phase	NA
Status	COMPLETED
Enrolment	14
Start date	Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Jul 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Covid19

Interventions

Carragelose
NaCl

Countries

Austria